Correlation Between Abcellera Biologics and Analog Devices
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Analog Devices at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Analog Devices into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and Analog Devices, you can compare the effects of market volatilities on Abcellera Biologics and Analog Devices and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Analog Devices. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Analog Devices.
Diversification Opportunities for Abcellera Biologics and Analog Devices
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Abcellera and Analog is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Analog Devices in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Analog Devices and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Analog Devices. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Analog Devices has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Analog Devices go up and down completely randomly.
Pair Corralation between Abcellera Biologics and Analog Devices
Given the investment horizon of 90 days Abcellera Biologics is expected to generate 2.4 times more return on investment than Analog Devices. However, Abcellera Biologics is 2.4 times more volatile than Analog Devices. It trades about 0.0 of its potential returns per unit of risk. Analog Devices is currently generating about -0.05 per unit of risk. If you would invest 289.00 in Abcellera Biologics on August 28, 2024 and sell it today you would lose (6.00) from holding Abcellera Biologics or give up 2.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Abcellera Biologics vs. Analog Devices
Performance |
| Timeline |
| Abcellera Biologics |
| Analog Devices |
Abcellera Biologics and Analog Devices Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Abcellera Biologics and Analog Devices
The main advantage of trading using opposite Abcellera Biologics and Analog Devices positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Analog Devices can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Analog Devices will offset losses from the drop in Analog Devices' long position.| Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |